Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company

Go back to Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company
(NASDAQ: MDCX) Delayed: 0.16 -0.01 (5.88%)
Previous Close $0.17    52 Week High
Open $0.17    52 Week Low
Day High $0.17    P/E N/A 
Day Low $0.16    EPS
Volume 18,088,942